Skip to main content

Find Clinical Trials

Home
Conditions
Rubella

Clinical trial condition

Rubella

Explore clinical trials studying Rubella. Study availability and eligibility vary by location and protocol.

58 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Rubella trial results

Completed

Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines

NCT00984295

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Not specified

View Trial Details

Completed

A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)

NCT00985166

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Not specified

View Trial Details

Completed

ProQuad Dose Selection Study (V221-011)(COMPLETED)

NCT00986232

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Not specified

View Trial Details

Completed

Making Decisions About the Measles-Mumps-Rubella Vaccine

NCT01369394

Conditions: Infections, MMR Vaccination, Measles, +15 more
Locations: UMHS Outpatient Pediatrics Ann Arbor, Michigan, United States

View Trial Details

Completed

Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers

NCT01188343

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +31 more
Locations: Taichung, Taiwan

Taipei, Taiwan

Taoyuan, Taiwan

View Trial Details

Completed

Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine

NCT00313950

Conditions: Digestive System Diseases, Enterovirus Infections, Hepatitis, +21 more
Locations: Izmir, Turkey (Türkiye)

View Trial Details

Completed

Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)

NCT01874457

Conditions: Infections, Measles, Mononegavirales Infections, +14 more
Locations: Bio-Manguinhos/Fiocruz Rio de Janeiro, Brazil

View Trial Details

Completed

Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes

NCT00351923

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany

GSK Investigational Site Bretten, Baden-Wurttemberg, Germany

GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany

GSK Investigational Site Karlsruhe, Baden-Wurttemberg, Germany

View all 20 locations

View Trial Details